Headquarters
USA

Owkin

The company deploys AI and federated learning for medical research and aims to empower researchers in hospitals, universities, and pharmaceutical companies to understand why drug efficacy varies from patient to patient, enhancethe drug development process, and identify the best drug for the right patient to improve treatment outcomes.

It was co-founded in 2016 by Thomas Clozel, a hematologist oncologist and researcher, and Gilles Wainrib, a computer science teacher-researcher in New York, New York.

Visit the Owkin website

1 articles from Owkin

Subscribe for updates

A weekly update of what’s on the Global Agenda

© 2021 World Economic Forum

Privacy Policy & Terms of Service